Document is current
Any future updates will be listed below
-
Authors
Pugliese, Nicola Riccardo
Paneni, Francesco
Tricò, Domenico
Bacca, Alessandra Violet
De Biase, Nicolò
Dalpiaz, Hermann
Mengozzi, Alessandro
Virdis, Agostino
Ghiadoni, Lorenzo
Taddei, Stefano
Kreutz, Reinhold
Tsioufis, Konstantinos
Masi, Stefano
-
Funding
Funding for this research was provided by:
Swiss National Science Foundation to Francesco Paneni (310030_197557)
Swiss Heart Foundation to Francesco Paneni (FF19045)
European Union–NextGenerationEU through the Italian Ministry of University and Research under PNRR-M4C2-I1.3 (PE_00000019 “HEAL ITALIA” to Stefano Taddei, CUP I53C22001440006)
European Union–NextGenerationEU through the Italian Ministry of University and Research under PNRR-M4C2-I1.3 (PE_00000019 “HEAL ITALIA” to Stefano Taddei, CUP I53C22001440006)
European Union–NextGenerationEU through the Italian Ministry of University and Research under PNRR-M4C2-I1.3 (PE_00000019 “HEAL ITALIA” to Stefano Taddei, CUP I53C22001440006)
- License Information
-
More Information
Article History
Received: 28 February 2025
Accepted: 6 May 2025
First Online: 22 May 2025
Declarations
:
: DT reports receiving fees for serving on advisory boards from Amarin, Boehringer Ingelheim and Novo Nordisk, lecture fees from Eli Lilly, and travel support from AstraZeneca. FP reports receiving fees for serving on advisory boards from Novo Nordisk. He also serves as Guest Editor for the thematic collection to which the current manuscript has been submitted; as such, has not been involved in the peer review process for this article.
